Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,540 | -1,450 | -7,160 | 0 | 0 |
| Depreciation Amortization | 210 | 0 | 0 | 0 | 0 |
| Other Working Capital | 720 | 0 | 0 | 0 | 0 |
| Other Operating Activity | 7,900 | 1,030 | 5,240 | 0 | 0 |
| Operating Cash Flow | $-6,710 | $-420 | $-1,920 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,110 | 0 | 0 | 0 | 0 |
| Net Acquisitions | 210 | 0 | 0 | 0 | 0 |
| Other Investing Activity | -110 | 60 | 1,900 | 0 | 0 |
| Investing Cash Flow | $-1,010 | $60 | $1,900 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,000 | 50 | 150 | 0 | 0 |
| Financing Cash Flow | $4,000 | $50 | $150 | $0 | $0 |
| Exchange Rate Effect | -7 | 0 | 0 | 0 | 0 |
| Beginning Cash Position | 7,040 | 510 | 380 | 0 | 0 |
| End Cash Position | 3,300 | 210 | 510 | 0 | 0 |
| Net Cash Flow | $-3,730 | $-300 | $120 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,710 | -420 | -1,920 | 0 | 0 |
| Free Cash Flow | -6,710 | -420 | -1,920 | 0 | 0 |